Non-Hodgkin lymphoma
Would you like to receive a message when there is new research on Non-Hodgkin lymphoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence above each publication explains what was studied — and you receive a notification as soon as new research on Non-Hodgkin lymphoma is available. View what Premium costs.
Publications and studies (2186)
- The epidemiology and prognosis of patients with primary gastric T-cell lymphoma in the SEER program. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Long-Term Complete Remission of a Patient With Double-Hit Diffuse Large B-Cell Lymphoma Treated by Chemoimmunotherapy and Chinese Herbal Medicine. (2023/01/01) ♡
- The Prognostic Impact of Pretreatment Geriatric Nutritional Risk Index in Patients with Diffuse Large B-Cell Lymphoma. (2023/01/01) ♡
- Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma. (2023/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides-Reply. (2023/01/01) ♡
- Organic food consumption and the incidence of cancer in the Danish diet, cancer and health cohort. (2023/01/01) ♡
- Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. (2023/01/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Selenium Supplementation Alter the Frequency of Th17 but not Th1/Th2 Lymphocytes in Diffuse Large B Cell Lymphoma Patients. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Artificially Sweetened Beverages Beyond the Metabolic Risks: A Systematic Review of the Literature. (2023/01/01) ♡
- An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. What does not look like celiac disease and instead it is. (2023/01/01) ♡
- Impact of Sarcopenia on Outcome of Exercise Therapy in Older Non-Hodgkin Lymphoma Patients. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Wernicke encephalopathy with extensive cortical lesions combined with diffuse large B-cell lymphoma. (2022/12/31) ♡
- Treatments for Relapsed-Refractory Diffuse Large B-cell Lymphoma: A Preliminary Evaluation of the Place in Therapy of Glofitamab, a Bispecific Monoclonal Antibody. (2022/12/31) ♡
- Hepatitis B and C infections among lymphoma patients: a national study in the Republic of Moldova. (2022/12/31) ♡
- A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera(®)) in patients with CD20-positive B-cell non-Hodgkin lymphoma. (2022/12/30) ♡
- Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas. (2022/12/30) ♡
- Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia. (2022/12/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Leukemia Cutis As the Initial Manifestation of Chronic Lymphocytic Leukemia Progression. (2022/12/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Cutaneous Anaplastic Large Cell Lymphoma With Gastric Metastasis. (2022/12/25) ♡
- Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001-2020. (2022/12/25) ♡
- Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line. (2022/12/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman. (2022/12/15) ♡
- [Interpretation of Chinese guidelines for diagnosis and treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (2022)]. (2022/12/14) ♡
- [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies]. (2022/12/14) ♡
- [Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma]. (2022/12/14) ♡
- [Clinical features and prognosis of eight patients with splenic diffuse red pulp small B-cell lymphoma]. (2022/12/14) ♡
- Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment. (2022/12/13) ♡
- Diversity of malignancies in patients with different types of inborn errors of immunity. (2022/12/12) ♡
- Proteomic Portrait of Human Lymphoma Reveals Protein Molecular Fingerprint of Disease Specific Subtypes and Progression. (2022/12/12) ♡
- Phase I study of novel SYK inhibitor TAK-659 (mivavotinib) in combination with R-CHOP for front-line treatment of high-risk diffuse large B-cell lymphoma. (2022/12/07) ♡
- Causal relationship between 14 site-specific cancers and venous thromboembolism. (2022/12/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diffuse large B-cell lymphoma: An uncommon diagnosis at the cerebellopontine angle - A case report. (2022/12/06) ♡
- Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis. (2022/12/01) ♡
- A prospective analysis of red blood cell membrane polyunsaturated fatty acid levels and risk of non-Hodgkin lymphoma. (2022/12/01) ♡
- The dual role of CD70 in B-cell lymphomagenesis. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma]. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Malignant Rectal B Cell Lymphoma That Was Difficult to Differentiate from Rectal Neuroendocrine Tumor]. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Peritoneal Lymphomatosis Diagnosed by Single-Port Laparoscopic Biopsy]. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [A Case of Diffuse Large B Cell Lymphoma of the Extrahepatic Bile Duct Cholangiocarcinoma]. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Patient with Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma with Small Intestinal Perforation Development during Chemotherapy]. (2022/12/01) ♡
- [Interpretation of the guidelines for diagnosis and treatment of mantle cell lymphoma in China (2022)]. (2022/11/14) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. [Bendamustine monotherapy for Chinese patient treatment with relapsed or refractory B cell non-Hodgkin lymphoma: a phase Ⅱ, prospective, multicenter, single-arm study]. (2022/11/14) ♡
- Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better. (2022/11/13) ♡
- Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. (2022/11/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma. (2022/11/01) ♡
- A β-glucan from Aureobasidium pullulans enhanced the antitumor effect with rituximab against SU-DHL-8. (2022/11/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review. (2022/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Unusual Case of High-Grade Non-Hodgkin Lymphoma Masquerading as Acute Pyelonephritis with Acute Kidney Injury. (2022/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type. (2022/11/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.